$Windtree Therapeutics (WINT.US)$
- 60 million shares traded before 7 AM , float of 11 million
- Biotech stock
- Plan for Reverse stock split in the next few months
- Analyst Rating in December was 7 $
- Has been aggressively sold and shorted for the past 4 months even with good news being released then
- Reached a low of 10 cents few days ago down from 3$ in September
- 200 EMA is at 6$
- 60 million shares traded before 7 AM , float of 11 million
- Biotech stock
- Plan for Reverse stock split in the next few months
- Analyst Rating in December was 7 $
- Has been aggressively sold and shorted for the past 4 months even with good news being released then
- Reached a low of 10 cents few days ago down from 3$ in September
- 200 EMA is at 6$
1
$Windtree Therapeutics (WINT.US)$ 2 days in a row with daily high volume and big green candles . Finally traders spotting this extremely oversold stock .
$Windtree Therapeutics (WINT.US)$ Shit show of a stock , DCB after DCB , endless short selling . If analysts say it's worth 7$ and its trading for 16 cents then someone is either lying or just zero sentiment and massive short selling and not wanting to buy back . Pitty
1
1
$Windtree Therapeutics (WINT.US)$ Wish to see the short sellers getting squeezed once more in this stock like back in July/August 2024 . Analysts' rating is 7 $ few weeks ago !
3
2
$Windtree Therapeutics (WINT.US)$ What is going on with the volume on Thursday , nearly 100% of outstanding shares were traded , price barely moved up or down .
They did announce a meeting in February though to vote on another reverse split
They did announce a meeting in February though to vote on another reverse split
$NuCana (NCNA.US)$ 20$ target price , 1.5 mil float and lowest ever now .
1
$Windtree Therapeutics (WINT.US)$ Analysts target price is 7 . Hope soon for a DCB or strong rise on the next good news
1
$Genprex (GNPX.US)$ Why selling it off this low , so oversold . analysts' target price is 7 $ . Sellers are just pushing this to another reverse stock split .
$Hoth Therapeutics (HOTH.US)$ Will it break the 1 dollar premarket
$Atara Biotherapeutics (ATRA.US)$ over 30 million cash in the books acccording to there 30th of June Financial report , will have additional extra cash of 36 million on 5 September from institutional investors and big pharma company by issuing them around 4 million shares at 8.25 $ , will further receive 20 million + 60 Million by Pierre Fabre Pharmaceuticals once FDA approves there EBV drug in Jan 2025 .
Should see increased acitivity soon as all these large investors have interest in this comp...
Should see increased acitivity soon as all these large investors have interest in this comp...
2